Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Relief Therapeutics Holding Days Sales Outstanding Chart
XSWX:RLF vs KTTA, OSRH, LIMN: Days Sales Outstanding Comparison
For the Biotechnology subindustry, Relief Therapeutics Holding's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Relief Therapeutics Holding Days Sales Outstanding vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Relief Therapeutics Holding's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Relief Therapeutics Holding's Days Sales Outstanding falls into.
Relief Therapeutics Holding Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Days Sales Outstanding of 150.88 mean?
Relief Therapeutics Holding (XSWX:RLF) has a Days Sales Outstanding of 150.88 as of Jun. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Relief Therapeutics Holding and its competitors. This is 100% above median its historical median of 75.38. Over the past decade, Relief Therapeutics Holding's Days Sales Outstanding has ranged from 48.67 to 143.10.
Is Relief Therapeutics Holding's Days Sales Outstanding too high?
Relief Therapeutics Holding's current Days Sales Outstanding of 150.88 is 100% above median its 10-year median of 75.38. Over the past 10 years, this metric has ranged from a low of 48.67 to a high of 143.10. The Biotechnology industry median Days Sales Outstanding is 69.03. Relief Therapeutics Holding's value of 150.88 is 118.6% above this industry median. Overall, Relief Therapeutics Holding has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Relief Therapeutics Holding's Days Sales Outstanding compare to KTTA and OSRH?
Relief Therapeutics Holding's Days Sales Outstanding of 150.88 can be compared against companies in the Biotechnology industry. The industry median Days Sales Outstanding is 69.03. Relief Therapeutics Holding's value of 150.88 is 118.6% above this benchmark. Historically, Relief Therapeutics Holding's own Days Sales Outstanding has ranged from 48.67 to 143.10 over the past decade. While the company's 10-year median is 75.38 vs. the industry median of 69.03, Relief Therapeutics Holding has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Biotechnology company?
The median Days Sales Outstanding among Biotechnology companies is 69.03, based on 837 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Relief Therapeutics Holding's current Days Sales Outstanding of 150.88 is 118.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Relief Therapeutics Holding and its competitors. For the Biotechnology industry, the median Days Sales Outstanding is 69.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Relief Therapeutics Holding's current Days Sales Outstanding is 150.88, which is 100% above median its own 10-year median of 75.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Relief Therapeutics Holding stock overvalued right now?
Relief Therapeutics Holding (XSWX:RLF) has a current Days Sales Outstanding of 150.88. The stock's GF Value™ is CHF6.28, compared to a current price of CHF3.00 — trading 52.2% below its estimated fair value. The current Days Sales Outstanding is 150.88, which is 100% above median its 10-year median of 75.38 and 118.6% above the Biotechnology industry median of 69.03. Relief Therapeutics Holding's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Relief Therapeutics Holding (XSWX:RLF), the current Days Sales Outstanding is 150.88 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Relief Therapeutics Holding (XSWX:RLF) Overvalued in 2026?
Based on GuruFocus' analysis, Relief Therapeutics Holding stock appears to be undervalued.
The current stock price of CHF3.00 is trading 52.2% below its estimated GF Value™ of CHF6.28.
Key valuation signals for XSWX:RLF:
Days Sales Outstanding: 150.88 (100% above median its 10-year median of 75.38)
GF Value™: CHF6.28 vs. price of CHF3.00 (52.2% below fair value)
Industry Position: 118.6% above the Biotechnology median
No single metric tells the full story. See the XSWX:RLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Relief Therapeutics Holding SA is engaged in the research, development, and commercialization of biopharmaceutical products. It mainly develops drugs of natural human origin. It has a focus on commercial products, and the development program pipeline is focused on three main areas: rare genetic, metabolic disorders, rare connective tissue disorders, and rare lung diseases. Its pipeline includes various drug candidates in their different stages of development, such as RLF-TD011 and RLF-100, among others. It also has commercial legacy products like Cambia, Setofilm, Voltadol, and Voltfast, among others. Geographically, the company generates a majority of its revenue from Europe (excluding Switzerland) and the rest from North America, Switzerland, and the rest of the world.
20GF Score
Get the complete analysis for XSWX:RLF
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:RLF has been successfully added to your 
